Venclose, Inc. clinical trials
Acquired by Becton, Dickinson and Company, 2021 · source ↗
The registry lists 2 studies whose lead sponsor is Venclose, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 27, 2022.
Before and after it joined Becton, Dickinson and Company
- First submitted before Venclose, Inc. became part of Becton, Dickinson and Company
- 2
- First submitted after Venclose, Inc. became part of Becton, Dickinson and Company
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Venclose, Inc.2 studies
Something wrong with this grouping? Tell us on the Becton, Dickinson and Company page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Becton, Dickinson and Company studies →
- Venclose RF Ablation System for the Treatment of IPVsCompletedNCT04386785Not applicable
Sponsor listed in the registry: Venclose, Inc. · First submitted before Venclose, Inc. became part of Becton, Dickinson and Company
- EU Post Market Clinical Follow-Up Study of the Venclose System for Saphenous Vein IncompetenceCompletedNCT04236245Not applicable
Sponsor listed in the registry: Venclose, Inc. · First submitted before Venclose, Inc. became part of Becton, Dickinson and Company